AMBISOME LIPOZOMAL AMFOTERICINA B 50mg powder for concentrate for infusion dispersion medication leaflet

J02AA01 amphotericin B • Antiinfectives for systemic use | Antimycotics for systemic use | Antibiotics

Amphotericin B is an antifungal medication used to treat severe and potentially life-threatening fungal infections. It is effective against a wide range of fungi, including Candida, Aspergillus, and Cryptococcus, and is used in systemic or invasive infections such as cryptococcal meningitis or invasive aspergillosis.

This medication works by binding to ergosterol in the fungal cell membrane, leading to the destruction of fungal cells. It is available as an injectable solution and is administered intravenously, usually in a hospital setting under strict medical supervision.

Amphotericin B can cause significant side effects, including fever, chills, nausea, vomiting, kidney damage, and electrolyte imbalances. For this reason, its use is reserved for severe cases, and patients require close monitoring during treatment.

Liposomal formulations of amphotericin B are better tolerated and have an improved safety profile, making them preferred in certain situations.

General data about AMBISOME LIPOZOMAL AMFOTERICINA B 50mg

Substance: amphotericin B

Commercial code: W71201001

Concentration: 50mg

Pharmaceutical form: powder for concentrate for infusion dispersion

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer: GILEAD SCIENCES IRELAND UC - IRLANDA

Holder: GILEAD SCIENCES IRELAND UC - IRLANDA

Number: 15/2025/01

Shelf life: 4 years dupa ambalare pt. comecializare; after the first opening-it is used immediately

Concentrations available for amphotericin B

50mg, 50mg/5ml, 5mg/ml